Combination Treatment with the GSK-3 Inhibitor 9-ING-41 and CCNU Cures Orthotopic Chemoresistant Glioblastoma in Patient-Derived Xenograft Models
Resistance to chemotherapy remains a major challenge in the treatment of human glioblastoma (GBM). Glycogen synthase kinase-3ß (GSK-3ß), a positive regulator of NF-?B–mediated survival and chemoresistance of cancer cells, has been identified as a potential therapeutic target in human GBM. Our object...
| Main Authors: | Ugolkov, A., Qiang, W., Bondarenko, G., Procissi, D., Gaisina, I., James, C., Chandler, J., Kozikowski, A., Gunosewoyo, Hendra, O'Halloran, T., Raizer, J., Mazar, A. |
|---|---|
| Format: | Journal Article |
| Published: |
2017
|
| Online Access: | http://hdl.handle.net/20.500.11937/56780 |
Similar Items
Characterization of Maleimide-Based Glycogen Synthase Kinase-3 (GSK-3) Inhibitors as Stimulators of Steroidogenesis
by: Gunosewoyo, Hendra, et al.
Published: (2013)
by: Gunosewoyo, Hendra, et al.
Published: (2013)
Inhibition of GSK-3 induces differentiation and impaired glucose metabolism in renal cancer
by: Pal, K., et al.
Published: (2014)
by: Pal, K., et al.
Published: (2014)
Structure-Guided Design of a Highly Selective Glycogen Synthase Kinase-3ß Inhibitor: A Superior Neuroprotective Pyrazolone Showing Antimania Effects
by: Chen, W., et al.
Published: (2011)
by: Chen, W., et al.
Published: (2011)
Colon cancer chemoresistance and chemosensitization
by: Shanmugam, M., et al.
Published: (2018)
by: Shanmugam, M., et al.
Published: (2018)
Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-κB regulated gene products in multiple myeloma xenograft mouse model
by: Siveen, K., et al.
Published: (2014)
by: Siveen, K., et al.
Published: (2014)
Study of chemoresistant CD133+ cancer stem cells from human glioblastoma cell line U138MG using multiple assays
by: Warrier, Sudha, et al.
Published: (2012)
by: Warrier, Sudha, et al.
Published: (2012)
From a4ß2 Nicotinic Ligands to the Discovery of σ1 Receptor Ligands: Pharmacophore Analysis and Rational Design
by: Yu, L., et al.
Published: (2012)
by: Yu, L., et al.
Published: (2012)
Identification of a Glycogen Synthase Kinase-3β Inhibitor that Attenuates Hyperactivity in CLOCK Mutant Mice
by: Kozikowski, A., et al.
Published: (2011)
by: Kozikowski, A., et al.
Published: (2011)
RECK in Osteosarcoma: A Novel Role in Tumour Vasculature and Inhibition of Tumorigenesis in an Orthotopic Mode
by: Clark, J., et al.
Published: (2011)
by: Clark, J., et al.
Published: (2011)
Molecular and cellular mechanisms of chemoresistance in pancreatic cancer
by: Adamska, Aleksandra, et al.
Published: (2018)
by: Adamska, Aleksandra, et al.
Published: (2018)
Rice-ing above
by: The Star, .
Published: (2025)
by: The Star, .
Published: (2025)
ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance.
by: Begicevic, R., et al.
Published: (2017)
by: Begicevic, R., et al.
Published: (2017)
Dysregulation of Nrf2 in hepatocellular carcinoma: Role in cancer progression and chemoresistance
by: Raghunath, A., et al.
Published: (2018)
by: Raghunath, A., et al.
Published: (2018)
New clinically relevant, orthotopic mouse models of human chondrosarcoma with spontaneous metastasis
by: Clark, J., et al.
Published: (2010)
by: Clark, J., et al.
Published: (2010)
STIR(ing) appearance of rhabdomyolysis
by: Chakera, Aron, et al.
Published: (2008)
by: Chakera, Aron, et al.
Published: (2008)
FACE-ing new knowledge
by: The Star,
Published: (2012)
by: The Star,
Published: (2012)
A help-ing hand
by: Yap, Ricky
Published: (2017)
by: Yap, Ricky
Published: (2017)
Shoe-ing out the president
by: Abd Razak, Dzulkifli
Published: (2009)
by: Abd Razak, Dzulkifli
Published: (2009)
GrowING The Business - ING Has Embarked On A Three Year Plan To Transform Itself
by: The Star, Cecilia Kok
Published: (2008)
by: The Star, Cecilia Kok
Published: (2008)
ADMiER-ing thin but complex fluids
by: McDonnell, A., et al.
Published: (2011)
by: McDonnell, A., et al.
Published: (2011)
Exploring the role of multidrug exporters and extracellular vesicles in medulloblastoma chemoresistance
by: Wade, Philippa
Published: (2024)
by: Wade, Philippa
Published: (2024)
Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3
by: Subramaniam, A., et al.
Published: (2013)
by: Subramaniam, A., et al.
Published: (2013)
Stemness and chemoresistance in epithelial ovarian carcinoma cells under shear stress
by: Ip, Carman K.M., et al.
Published: (2016)
by: Ip, Carman K.M., et al.
Published: (2016)
NGAL is downregulated in oral squamous cell carcinoma and leads to increased survival, proliferation, migration and chemoresistance
by: Monisha, J., et al.
Published: (2018)
by: Monisha, J., et al.
Published: (2018)
Emodin suppresses migration and invasion through the modulation of CXCR4 expression in an orthotopic model of human hepatocellular carcinoma
by: Manu, K., et al.
Published: (2013)
by: Manu, K., et al.
Published: (2013)
GSK-3β phosphorylation and alteration of β-catenin in hepatocellular carcinoma
by: Ban, Ke Chen, et al.
Published: (2003)
by: Ban, Ke Chen, et al.
Published: (2003)
Queer(y)ing Illiberal Pragmatism in Singapore
by: Offord, Baden
Published: (2014)
by: Offord, Baden
Published: (2014)
Targeting DNA repair for personalisation of glioblastoma therapy
by: Perry, Christina Joy
Published: (2016)
by: Perry, Christina Joy
Published: (2016)
Enhanced dendritic cell immunotherapy to treat glioblastoma
by: Adhikaree, Jason
Published: (2019)
by: Adhikaree, Jason
Published: (2019)
Recent advances in the therapeutic strategies of glioblastoma multiforme
by: Aldoghachi, Asraa Faris, et al.
Published: (2022)
by: Aldoghachi, Asraa Faris, et al.
Published: (2022)
Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer
by: Elaskalani, O., et al.
Published: (2017)
by: Elaskalani, O., et al.
Published: (2017)
Establishing a Bioluminescent Screening Platform to Identify Stromal-Mediated Chemoresistance in Leukaemia
by: Panting, Rhiannon
Published: (2024)
by: Panting, Rhiannon
Published: (2024)
Structural analogs of huperzine A improve survival in guinea pigs exposed to soman
by: Gunosewoyo, Hendra, et al.
Published: (2013)
by: Gunosewoyo, Hendra, et al.
Published: (2013)
Study On The Creative Process Of VJ-Ing In Kuala Lumpur
by: Mat Yusoff, Nur Huda
Published: (2011)
by: Mat Yusoff, Nur Huda
Published: (2011)
Development of orthotopic breast cancer and detection of nNav 1.5 serum antibody in syngeneic mouse model
by: Noor, Aina Akmal Mohd
Published: (2019)
by: Noor, Aina Akmal Mohd
Published: (2019)
Comparative studies on the mechanical strength, composition and microstructure of ovine and porcine cortical xenografts
by: Liu, Shaomin, et al.
Published: (2009)
by: Liu, Shaomin, et al.
Published: (2009)
Characterization and chemoresistance of HT29 (Colon cancer) and TW06 (Nasopharyngeal cancer) tumorspheres
by: Goh, Iris Wen Li
Published: (2014)
by: Goh, Iris Wen Li
Published: (2014)
Chlorotoxin as a Drug Delivery System to treat Glioblastoma
by: Fawzy, Ahmed Faadil
Published: (2021)
by: Fawzy, Ahmed Faadil
Published: (2021)
Development of an EGFR-targeted Drug Delivery System for Glioblastoma
by: Zhao, Zi-Ruo
Published: (2023)
by: Zhao, Zi-Ruo
Published: (2023)
MicroRNA regulation of glycolytic metabolism in glioblastoma multiforme
by: Alfardus, Huda, et al.
Published: (2017)
by: Alfardus, Huda, et al.
Published: (2017)
Similar Items
-
Characterization of Maleimide-Based Glycogen Synthase Kinase-3 (GSK-3) Inhibitors as Stimulators of Steroidogenesis
by: Gunosewoyo, Hendra, et al.
Published: (2013) -
Inhibition of GSK-3 induces differentiation and impaired glucose metabolism in renal cancer
by: Pal, K., et al.
Published: (2014) -
Structure-Guided Design of a Highly Selective Glycogen Synthase Kinase-3ß Inhibitor: A Superior Neuroprotective Pyrazolone Showing Antimania Effects
by: Chen, W., et al.
Published: (2011) -
Colon cancer chemoresistance and chemosensitization
by: Shanmugam, M., et al.
Published: (2018) -
Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-κB regulated gene products in multiple myeloma xenograft mouse model
by: Siveen, K., et al.
Published: (2014)